Gewählte Publikation:
SHR
Neuro
Krebs
Kardio
Lipid
Stoffw
Microb
Greinix, HT; Worel, N; Just, U; Knobler, R.
Extracorporeal photopheresis in acute and chronic graft-versus-host disease.
Transfus Apher Sci. 2014; 50(3):349-357
Doi: 10.1016/j.transci.2014.04.005
Web of Science
PubMed
FullText
FullText_MUG
- Führende Autor*innen der Med Uni Graz
-
Greinix Hildegard
- Altmetrics:
- Dimensions Citations:
- Plum Analytics:
- Scite (citation analytics):
- Abstract:
-
Graft-versus-host disease (GvHD) is a serious complication of allogeneic hematopoietic cell transplantation causing significant morbidity and mortality. Corticosteroids are the established first-line treatment of GvHD. Patients not responding to corticosteroids have a dismal prognosis. Extracorporeal photopheresis (ECP) has objective activity in the treatment of both acute and chronic corticosteroid-refractory GvHD patients, has an excellent safety profile and is internationally well-established. ECP has been recommended by a significant number of renowned scientific organizations as an efficient treatment option for patients with GvHD. ECP has a proven corticosteroid-sparing effect and favourably impacts on survival and quality of life of responding patients.
Copyright © 2014 Elsevier Ltd. All rights reserved.
- Find related publications in this database (using NLM MeSH Indexing)
-
Acute Disease -
-
Allografts -
-
Chronic Disease -
-
Graft vs Host Disease - immunology
-
Graft vs Host Disease - therapy
-
Hematopoietic Stem Cell Transplantation -
-
Humans -
-
Photopheresis - methods
- Find related publications in this database (Keywords)
-
Extracorporeal photopheresis
-
Graft-versus-host disease